270 related articles for article (PubMed ID: 19279567)
1. A critical appraisal of the safety and efficacy of drug-eluting stents.
Maluenda G; Lemesle G; Waksman R
Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stents: issues of late stent thrombosis.
Lemesle G; Maluenda G; Collins SD; Waksman R
Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stent safety.
Slottow TL; Waksman R
Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
[TBL] [Abstract][Full Text] [Related]
4. Safety of drug-eluting stents.
Windecker S; Jüni P
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
[TBL] [Abstract][Full Text] [Related]
5. Off-label use of stents: bare-metal versus drug-eluting stents.
Girod JP; Mulukutla SR; Marroquin OC
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
7. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
8. Technology Insight: an overview of research in drug-eluting stents.
Ong AT; Serruys PW
Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):647-58. PubMed ID: 16306921
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
10. Design criteria for the ideal drug-eluting stent.
Ako J; Bonneau HN; Honda Y; Fitzgerald PJ
Am J Cardiol; 2007 Oct; 100(8B):3M-9M. PubMed ID: 17950830
[TBL] [Abstract][Full Text] [Related]
11. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
12. Current status of drug-eluting stents.
Räber L; Windecker S
Cardiovasc Ther; 2011 Jun; 29(3):176-89. PubMed ID: 20370793
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis comparing the effect of drug-eluting versus bare metal stents on risk of acute myocardial infarction during follow-up.
Moreno R; Fernández C; Calvo L; Sánchez-Recalde A; Galeote G; Sanchez-Aquino R; Alfonso F; Macaya C; López-Sendón JL
Am J Cardiol; 2007 Mar; 99(5):621-5. PubMed ID: 17317360
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents: limitations of early generation and progress with newer generation devices.
Khattab AA; Windecker S
Minerva Med; 2010 Feb; 101(1):9-23. PubMed ID: 20228717
[TBL] [Abstract][Full Text] [Related]
15. [Expectation for new-generation drug eluting stents].
Saito S
Nihon Rinsho; 2011 Feb; 69(2):237-9. PubMed ID: 21387669
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stents for coronary artery disease: a review.
Martin DM; Boyle FJ
Med Eng Phys; 2011 Mar; 33(2):148-63. PubMed ID: 21075668
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL
Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of drug-eluting stents: on-label and off-label perspectives.
Weisz G; Stone GW
Rev Cardiovasc Med; 2008; 9(1):46-61. PubMed ID: 18418309
[TBL] [Abstract][Full Text] [Related]
20. Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV; Nakazawa G; Virmani R
Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
